Lilly hands Elan manufacturing first major contract
Ireland's Elan has signed its first major contract manufacturing and supply agreement in a development that reinforces its credentials as a player in the outsourcing sector.
Archives for June 15, 2004
Irish firm adds diversity to chiral catalyst sector
Irish start-up Celtic Catalysts believes it can tackle two of the major obstacles holding back the use of catalysts to make chiral drugs - the strong patent positions of existing players and difficulties in scale-up - with its platform technology,...
European RNAi conference
A conference on the hot topic of RNA interference will be held in London, UK in October, with the keynote address delivered by leading RNAi researcher Craig Mello.
Try outsourcing to control spiralling R&D budgets
Companies developing new drugs for the global market must deal with the rising costs of the R&D process - and outsourcing may well be the best route, according to Dr Faiz Kermani, a specialist in outsourcing and research development.
Over-boxing the answer to parallel trade risks?
The European Union parallel trade in pharmaceuticals is offering few benefits to cash-strapped national healthcare systems and may raise the risk of medication errors and entry of counterfeit medicines into the supply chain, according to a new report.
Trade dress victory for re-packagers
In Norway, the Supreme Court has concluded that the packaging designused by the local subsidiary of parallel importer Paranova does notinfringe Merck & Co's trademarks.
EU grant for 3D genomics research
The European Union has awarded funding worth €2.2 million to the group of academic institutes behind the 3DGENOME research programme, which is exploring how the genome functions in health and disease.
Axon releases world's first single-cell electroporator
Drug discovery instrumentation and software developer Axon Instruments announced today the release of its Axoporator 800A single-cell electroporator, the first commercially available instrument of its kind, writes Wai Lang Chu.
Hovione extends drug delivery alliance
Hovione of Portugal has teamed up with drug delivery company CyDex to develop improved formulations of drugs that have lost or will soon lose patent protection.